← Back to Search

Multimodal Lab Test Strategy for Health Care Utilization

N/A
Recruiting
Led By Anshula Ambasta
Research Sponsored by University of Calgary
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 years
Awards & highlights

Study Summary

This trial will reduce unnecessary lab tests in 30 hospitals to improve patient outcomes, reduce healthcare costs, and decrease discomfort.

Who is the study for?
This trial is for patients and healthcare providers in adult medical and hospitalist units within participating hospitals in Alberta and British Columbia. It excludes those outside these provinces, non-enrolled hospitals, or units like ICU, surgical, pediatric, or obstetrical.Check my eligibility
What is being tested?
The study tests a multimodal intervention to reduce unnecessary lab testing in hospitalized patients. This includes education for clinicians, audit reports on test ordering habits, system changes to support better decision-making, and patient infographics.See study design
What are the potential side effects?
Since this trial focuses on changing procedures rather than testing drugs or medical devices, it does not have typical side effects. However unintended consequences may include variations in clinician behavior or patient care processes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of routine laboratory tests ordered per patient-day in the intervention versus control periods
Secondary outcome measures
30-day post discharge readmission rate
Costs associated with routine and all common laboratory test ordered
In-patient and 30-day patient mortality over a 7-year period
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Exposed to intervention (intervention period)Experimental Treatment4 Interventions
This is the time period of the study where hospital clusters are receiving the multimodal intervention.
Group II: Unexposed to intervention (control period)Active Control1 Intervention
This is the time period of the study where hospital clusters are not receiving the intervention

Find a Location

Who is running the clinical trial?

University of British ColumbiaOTHER
1,418 Previous Clinical Trials
2,215,301 Total Patients Enrolled
University of CalgaryLead Sponsor
792 Previous Clinical Trials
617,337 Total Patients Enrolled
Alberta Health servicesOTHER
158 Previous Clinical Trials
397,849 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What key results is the research team seeking to achieve with this trial?

"This 4-year long study will primarily evaluate the aggregate number of laboratory tests ordered per day. Secondary metrics include hospital patient lab-free days, critically abnormal test results, and length of stay on a given unit."

Answered by AI

What is the maximum capacity of patients for this clinical research program?

"Affirmative. The data hosted on clinicaltrials.gov verifies that this medical trial, which was initially posted on 2nd January 2023, is actively enrolling participants. At the present time, 503633 individuals must be recruited from two locations across the United States of America."

Answered by AI

Is this trial accepting new participants?

"Affirmative. Per the latest data on clinicaltrials.gov, this experiment is still in need of participants - with a total recruitment target of 503633 people across 2 sites since it was first posted on January 2nd 2023 and last edited on October 31st 2023."

Answered by AI
~111919 spots leftby Apr 2025